Jolt Health Inc. (CSE:JOLT)
Canada · Delayed Price · Currency is CAD 0.0350
-0.0050 (-12.50%)
At close: Jul 31, 2026
Jolt Health Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0 | 0 | 0 | 0 | 0.04 | 0.33 |
Short-Term Investments | - | - | - | - | - | 0.18 |
Cash & Short-Term Investments | 0 | 0 | 0 | 0 | 0.04 | 0.52 |
Cash Growth | -22.73% | -34.08% | -58.67% | -95.05% | -91.94% | -2.77% |
Other Receivables | 0 | 0 | 0 | 0 | 0.01 | 0.01 |
Receivables | 0 | 0 | 0 | 0 | 0.11 | 0.04 |
Prepaid Expenses | 0.01 | 0.01 | 0.02 | 0.01 | 0.06 | 0.07 |
Total Current Assets | 0.01 | 0.01 | 0.03 | 0.02 | 0.21 | 0.63 |
Long-Term Investments | - | - | 0.1 | 0.36 | 0.61 | 0.68 |
Other Intangible Assets | - | - | - | - | - | 0.51 |
Total Assets | 0.01 | 0.01 | 0.12 | 0.37 | 0.82 | 1.82 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.51 | 0.72 | 0.85 | 0.45 | 0.28 | 0.26 |
Accrued Expenses | 0.37 | 0.05 | 0.06 | 0.05 | 0.06 | - |
Short-Term Debt | 0.01 | 0 | 0.03 | - | 0.09 | 0.22 |
Current Unearned Revenue | - | - | - | - | - | 0.12 |
Total Current Liabilities | 0.89 | 0.77 | 0.93 | 0.5 | 0.43 | 0.61 |
Long-Term Debt | - | - | - | - | 0.06 | - |
Other Long-Term Liabilities | - | - | - | - | 0.15 | - |
Total Liabilities | 0.89 | 0.77 | 0.93 | 0.5 | 0.63 | 0.61 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 13.43 | 13.43 | 12.86 | 12.62 | 12.24 | 10.11 |
Retained Earnings | -15.83 | -15.71 | -15.19 | -14.02 | -13.26 | -9.68 |
Comprehensive Income & Other | 1.52 | 1.52 | 1.52 | 1.27 | 1.21 | 0.78 |
Shareholders' Equity | -0.88 | -0.76 | -0.81 | -0.13 | 0.19 | 1.21 |
Total Liabilities & Equity | 0.01 | 0.01 | 0.12 | 0.37 | 0.82 | 1.82 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0.01 | 0 | 0.03 | - | 0.15 | 0.22 |
Net Cash (Debt) | -0.01 | -0 | -0.03 | 0 | -0.1 | 0.29 |
Net Cash Growth | - | - | - | - | - | -7.87% |
Net Cash Per Share | -0.00 | -0.00 | -0.00 | 0.00 | -0.05 | 0.27 |
Filing Date Shares Outstanding | 12.73 | 12.73 | 6.36 | 6.36 | 2.52 | 1.66 |
Total Common Shares Outstanding | 12.73 | 12.73 | 6.36 | 3.86 | 2.52 | 1.57 |
Working Capital | -0.88 | -0.76 | -0.91 | -0.48 | -0.22 | 0.02 |
Book Value Per Share | -0.07 | -0.06 | -0.13 | -0.03 | 0.07 | 0.77 |
Tangible Book Value | -0.88 | -0.76 | -0.81 | -0.13 | 0.19 | 0.7 |
Tangible Book Value Per Share | -0.07 | -0.06 | -0.13 | -0.03 | 0.07 | 0.45 |